For this purpose, levels of FASN, phosphorylated/activated (p-)AKT at serine 473, and c-Met were determined in a collection of human HCC specimens (n = 94; Supplementary Table 1) by immunohistochemistry (Fig. 7). This evidence concerns the gene AKT1 and hepatocellular carcinoma.